Health Canada
- Status: approved
L-leucine (L-leucine) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Federal Scientific Clinical Centre of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogache is the originator. The local marketing authorisation holder may differ — check the official source linked above.